To estimate the proportion of patients treated with caspofungin reporting one or more clinical and/or laboratory drug-related adverse experience(s) during the study drug therapy period plus 14 days posttherapy
Proportion of patients with a favorable overall response
2 Years to 17 Years (Child)
0991-044 Formerly-0404ETPP MK0991-044 2004_101
May 13, 2004
February 23, 2017
† Study has passed its completion date and status has not been verified in more than two years.